Analyze Diet
Veterinary parasitology1995; 60(1-2); 103-110; doi: 10.1016/0304-4017(94)00763-3

Dose titration of moxidectin oral gel against migrating Strongylus vulgaris and Parascaris equorum larvae in pony foals.

Abstract: Moxidectin was tested for efficacy in ponies against experimental infections of 56 day Strongylus vulgaris larvae and 11 day Parascaris equorum larvae. Three dosages of moxidectin were tested: 300 micrograms per kg live body weight, 400 micrograms per kg, and 500 micrograms per kg, and the vehicle served as control. Ponies were first infected with 600 S. vulgaris third-stage larvae (L3) on Experiment Day 0 and then with 3000 embryonated P. equorum eggs on Day 45. Moxidectin treatments were administered on Day 56 and necropsy examinations were performed on Day 91. Strongylus vulgaris fourth-stage (L4) and fifth-stage (L5) larvae were recovered at necropsy from the control ponies, in dissections of the cranial mesenteric artery and its branches (L4 and L5), and recovered from nodules in the wall of the cecum and ventral colon (L5). Parascaris equorum larvae were recovered from the small intestine of control ponies. Moxidectin was highly efficacious against S. vulgaris L4 and L5 at all three doses tested (99.6-100%), and appeared to be equally efficacious against P. equorum larvae (100%); however, control ponies had low levels of P. equorum infections compared to previous experimental infections performed using identical methods. This suggests that the prior S. vulgaris infection on Day 0 may have influenced the subsequent experimental P. equorum infection on Day 45 and contributed to the lower recovery.
Publication Date: 1995-11-01 PubMed ID: 8644446DOI: 10.1016/0304-4017(94)00763-3Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article explores the efficacy of different dosages of moxidectin oral gel against two parasitic larvae infections in pony foals. The infections targeted were from Strongylus vulgaris and Parascaris equorum. The research confirmed that moxidectin was highly effective in all tested doses.

Experimental Design

  • The study worked with pony foals that were experimentally infected with the parasites Strongylus vulgaris and Parascaris equorum, specifically 56 day old S. vulgaris larvae and 11 day old P. equorum larvae.
  • Three different doses of moxidectin were used for testing: 300, 400, and 500 micrograms per kg of the pony’s live body weight. A control group was administered with the vehicle only.
  • The pony foals were initially infected with 600 third-stage S. vulgaris larvae and subsequently with 3000 embryonated P. equorum eggs, this was carried out on Day 0 and Day 45 respectively.
  • The various moxidectin treatments were given on Day 56 and necropsy examinations were performed on Day 91 to evaluate the effects.

Findings

  • At necropsy, fourth and fifth-stage S. vulgaris larvae were found in the control ponies, located in the cranial mesenteric artery and its branches, and in nodules in the wall of the cecum and ventral colon. P. equorum larvae were found in the small intestine of control ponies.
  • Moxidectin showed high efficacy against both S. vulgaris and P. equorum larvae at all dosage levels tested. The effect was almost total, showing 99.6-100% efficacy.
  • It is noted that control ponies had comparatively low levels of P. equorum infections when compared to previous experimental infections. The authors theorize that the initial S. vulgaris infection on Day 0 may have had an impact on the later P. equorum infection on Day 45, contributing to this lower recovery.

Implications

  • The results of this study show that moxidectin oral gel is a highly effective treatment against migrating S. vulgaris and P. equorum larvae in pony foals.
  • The observation that the initial S. vulgaris infection affected the subsequent P. equorum infection suggests that further investigation into the relationship between these two parasitic larvae and their infections in ponies may be valuable.

Cite This Article

APA
Monahan CM, Chapman MR, Taylor HW, French DD, Klei TR. (1995). Dose titration of moxidectin oral gel against migrating Strongylus vulgaris and Parascaris equorum larvae in pony foals. Vet Parasitol, 60(1-2), 103-110. https://doi.org/10.1016/0304-4017(94)00763-3

Publication

ISSN: 0304-4017
NlmUniqueID: 7602745
Country: Netherlands
Language: English
Volume: 60
Issue: 1-2
Pages: 103-110

Researcher Affiliations

Monahan, C M
  • Department of Veterinary Microbiology and Parasitology, Louisiana State University, Baton Rouge 70803, USA.
Chapman, M R
    Taylor, H W
      French, D D
        Klei, T R

          MeSH Terms

          • Administration, Topical
          • Animals
          • Animals, Newborn
          • Anthelmintics / administration & dosage
          • Anthelmintics / therapeutic use
          • Anti-Bacterial Agents
          • Ascaridida Infections / drug therapy
          • Ascaridida Infections / veterinary
          • Ascaridoidea / drug effects
          • Ascaridoidea / isolation & purification
          • Ascaridoidea / physiology
          • Dose-Response Relationship, Drug
          • Equidae
          • Gels
          • Larva
          • Macrolides / administration & dosage
          • Macrolides / therapeutic use
          • Strongylida Infections / drug therapy
          • Strongylida Infections / veterinary
          • Strongylus / drug effects
          • Strongylus / isolation & purification
          • Strongylus / physiology

          Citations

          This article has been cited 1 times.
          1. DeLay J, Peregrine AS, Parsons DA. Verminous arteritis in a 3-month-old thoroughbred foal.. Can Vet J 2001 Apr;42(4):289-91.
            pubmed: 11326632